Feedback

Three AstraZeneca vaccinated doctors hospitalized with blood clots in Norway

Source : 112 Ukraine

Doctors undergo hospital treatment
21:21, 13 March 2021

vaccination
Open source

In Norway, three doctors were hospitalized with blood clots. The day before, they were vaccinated against the coronavirus with AstraZeneca vaccine. This is reported by Aftenposten.

“Today, March 13, we received reports of serious cases of blood clots in three young doctors who received the AstraZeneca vaccine. They are being treated in a hospital,” said the Norwegian Institute of Health.

In this regard, the National Institute of Public Health and the Norwegian Medicines Agency urgently called a conference.

The Norwegian Ministry of Health announced yesterday that it is suspending the use of the AstraZeneca vaccine. The reason for this is the appearance of blood clots in patients who were vaccinated against coronavirus.

Earlier it became known that in Denmark, Austria, Estonia, Latvia, Lithuania and Luxembourg, the use of the AstraZeneca vaccine was temporarily suspended.

Related: Coronavirus mapping dashboard: world online

The S&P Global Ratings predicts that by the middle of this year, Ukraine will be able to vaccinate (full vaccination consists of two doses) only 2.7% of the population against coronavirus. This is stated on the agency's website.

It is noted that in the first half of 2021, Ukraine should receive 2.3 million doses out of 8 million guaranteed - as part of the COVAX initiative. If we take into account the fact that a complete vaccination against Covid-19 consists of two doses of the drug, then only 2.7% of the population can be vaccinated with this amount.

At the same time, the agency notes that the country's authorities expect 25 million doses from various sources, which is enough to immunize 30% of the population with two doses.

Related: Covid-19 pandemic leads to the birth of 1.4 million unplanned children

 

Topics:
Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

Comments
see more